Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Taste and Smell Impairment in Critically Ill COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04532632
Recruitment Status : Completed
First Posted : August 31, 2020
Last Update Posted : November 10, 2020
Sponsor:
Information provided by (Responsible Party):
Pinar Ay Sayin, Sisli Hamidiye Etfal Training and Research Hospital

Brief Summary:
Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

Condition or disease
Smell Disorder Taste Disorders Coronavirus Infection

Detailed Description:
Patients who were treated in the intensive care unit of Şişli Hamidiye Etfal Training and Research Hospital with the diagnosis of Coronavirus disease-19 will be determined by scanning the hospital registry system. It was planned that patients discharged from the intensive care unit would be called by phone and their complaints about smell and taste disorders were evaluated with a questionnaire.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 40 participants
Observational Model: Other
Time Perspective: Prospective
Target Follow-Up Duration: 10 Days
Official Title: Taste and Smell Impairment in Critically Ill COVID-19 Patients
Actual Study Start Date : September 1, 2020
Actual Primary Completion Date : October 1, 2020
Actual Study Completion Date : October 9, 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. taste and smell impairment [ Time Frame: up to 3 months ]
    incidence of taste and smell impairment in critically ill subjects



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients between the ages of 18-80, who were treated in the intensive care unit with the diagnosis of Coronavirus disease-19 and were discharged
Criteria

Inclusion Criteria:

  • Adults between the ages of 18-80
  • Agree to participate in the study
  • Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19

Exclusion Criteria:

  • Pre-existing smell and taste impairment
  • The patients have no enough cooperation to answer the questionnaire
  • Having additional diseases such as dementia and Alzheimer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04532632


Locations
Layout table for location information
Turkey
Sisli Etfal Research and Training Hospital
Istanbul, Turkey, 34371
Sponsors and Collaborators
Pinar Ay Sayin
Publications:
Layout table for additonal information
Responsible Party: Pinar Ay Sayin, specialist medical doctor, Sisli Hamidiye Etfal Training and Research Hospital
ClinicalTrials.gov Identifier: NCT04532632    
Other Study ID Numbers: 3334-02
First Posted: August 31, 2020    Key Record Dates
Last Update Posted: November 10, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Pinar Ay Sayin, Sisli Hamidiye Etfal Training and Research Hospital:
Coronavirus disease-19
anosmia
hyposmia
dysgeusia
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronavirus Infections
Severe Acute Respiratory Syndrome
Taste Disorders
Olfaction Disorders
Disease
Pathologic Processes
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases